Stanley Black & Decker
SWK
$115.62
-0.70%
Stanley Black & Decker, Inc. is a diversified industrial manufacturer whose Tools & Outdoor segment (DeWALT, Craftsman, Stanley, Hustler) produces power tools, hand tools, storage, and outdoor power equipment, complemented by an Engineered Fastening business serving automotive and industrial customers, with the United States as its largest market. The company is a scaled, brand-owning incumbent in a mature tools and hardware industry, competing on brand equity, professional-channel relationships, and manufacturing scale rather than on rapid innovation cycles. The current investor narrative centers on a margin-recovery and portfolio-simplification story: gross margin has climbed sharply year over year (38.95% in the latest quarter versus 30.65% a year earlier) and operating margin has expanded, while the company has been actively paying down debt and repurchasing stock. That improving profitability, combined with a recent earnings-driven re-rating of the shares, has shifted the debate from balance-sheet repair toward whether the earnings recovery is durable enough to justify the stock's sharp move off its lows.…
SWK
Stanley Black & Decker
$115.62
Investment Opinion: Should I buy SWK Today?
Rating: Hold. The core thesis is that SWK's margin-recovery story is real and well-documented — gross margin expanded 830bps year over year to 38.95% and Q3 EPS jumped to $1.84 from $0.34 — but the stock at $114.85 has already run past the $112.00 average analyst target (roughly -2.5% implied downside) after a 70.22% one-year and 30.05% one-month surge, leaving little near-term reward for new capital. The 2.47 recommendation mean, with 11 of 15 ratings at Hold and zero Sells, frames this as a fairly-valued recovery rather than a fresh opportunity.
The supporting evidence is genuinely constructive: forward PE of 17.65x against consensus EPS of $8.87 is undemanding for a branded industrial, price-to-book of 1.28x sits in the lower half of its 1.13x–1.86x historical band, and PEG of 0.82 signals growth-adjusted value. Free cash flow of $1.72 billion ($585 million in Q3 alone on just $73.5 million of capex) comfortably funds the 4.32% dividend despite the 1.25x GAAP payout ratio, and debt-to-equity has fallen to 0.66 as roughly $1.75 billion of debt was repaid in Q2. The offset is that revenue is flat — Q3 fell 0.65% to $3.732 billion — so the entire earnings inflection rests on cost and pricing actions, and trailing net margin of 2.66% and ROE of 4.44% show how much recovery is still unproven.
The biggest risks that could invalidate this view are a Q4 gross-margin give-back toward the low-30s on promotional pricing, a demand downturn that pressures both margins and the $92.3 million quarterly interest burden simultaneously, and simple mean reversion after a 13% single-session gap that a 4.99 short ratio may have amplified. This Hold would upgrade to Buy if the stock pulled back toward the $96–$100 zone (near the analyst low target) while gross margin held near 39%, or if revenue growth turned positive; it would downgrade to Sell if gross margin slipped below roughly 33% or if forward EPS estimates fell below $8.00. Net verdict: fairly valued to modestly overextended relative to consensus after the re-rating, but not expensive on forward earnings — a stock to own on weakness, not to chase at $114.85.
Sign up to view all
SWK 12-Month Price Forecast
The forward view is balanced: the fundamental recovery is real and cash-backed, but the price already reflects much of it. At 17.65x forward earnings against $8.87 consensus EPS, SWK is not expensive for a branded industrial, and the 1.28x book multiple sits in the lower half of its historical band — yet the stock is above the $112 average target after a 70% one-year run, and the sell-side is overwhelmingly neutral. The base case (55% probability, $105–$118) assumes margins settle in the mid-to-high 30s and the stock consolidates around consensus fair value. I would upgrade to bullish if Q4 confirms gross margin near 39% and revenue turns positive, or if the stock pulls back toward $96–$100 while the recovery holds; I would downgrade to bearish if gross margin slips below roughly 33% or forward EPS estimates fall below $8.00.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Stanley Black & Decker's 12-month outlook, with a consensus price target around $112.00 and implied upside of -3.1% versus the current price.
Average Target
$112.00
15 analysts
Implied Upside
-3.1%
vs. current price
Analyst Count
15
covering this stock
Price Range
$96 - $140
Analyst target range
Coverage is moderate, with 11 analysts contributing ratings: 4 Buy, 11 Hold, and 0 Sell, yielding a recommendation mean of 2.47 that leans neutral-to-cautious despite the headline "buy" label. The average target price of $112.00 sits slightly below the current $114.85, implying roughly -2.5% downside to consensus, a notable signal that the stock has run past the average analyst's fair value after its 30% one-month surge. Consensus revenue of $17.00 billion and EPS of $8.87 for the forward period underpin the forward PE of 17.65x.
The target range of $96.00 to $140.00 is wide, spanning about 46% from low to high, which signals genuine disagreement about the durability of the margin recovery. The $140 high target implies further multiple expansion and confidence that gross margins hold near 39% with continued deleveraging, while the $96 low target assumes margin compression or demand deterioration that stalls the earnings rebound. Recent institutional actions show a split house: Citigroup reiterated Buy on 2026-11-05 and Mizuho maintained Outperform on 2026-10-15, while Wells Fargo has repeatedly stayed at Equal Weight and JP Morgan has held Underweight since May 2026 — a pattern of cautious neutrality that, combined with the average target below the current price, suggests limited near-term analyst-driven upside.
Bulls vs Bears: SWK Investment Factors
The bull case currently has stronger evidence: the margin recovery is documented across three consecutive quarters, free cash flow of $1.72 billion is real, and the forward PE of 17.65x is undemanding for a branded industrial. The bear case is not about fundamentals deteriorating but about price — the stock has already gained 70% in a year and trades above the $112 average analyst target with 11 of 15 ratings at Hold. The single most important tension is whether the 38.95% gross margin is durable or a peak: if it holds near 39% through a seasonally weaker Q4 and into 2027, the forward multiple looks cheap and the stock can grind toward the $140 high target; if margin compresses back toward the low-30s, the earnings rebound stalls and the stock retraces toward the $96 low target. Revenue stagnation is the quiet constraint on both sides — margin expansion alone can carry earnings only so far without top-line growth.
Bullish
- Gross margin up 830bps YoY: Q3 2026 gross margin reached 38.95% versus 30.65% a year earlier, an 830-basis-point expansion that flowed straight to the bottom line. The sequential path through 2026 (30.09% in Q1, 32.97% in Q2, 38.95% in Q3) shows pricing, cost actions, and productivity gains compounding rather than a one-off accounting benefit.
- Earnings inflected sharply in Q3: Q3 2026 net income hit $272.1 million (EPS $1.84) versus just $51.4 million a year earlier, lifting net margin to 7.29% from 1.37% and operating margin to 13.17% from 9.70%. Consensus forward EPS of $8.87 against trailing EPS of $0.035 confirms the market is pricing a genuine normalization, not a fluke.
- Strong free cash flow and deleveraging: Trailing free cash flow is $1.72 billion, with $585 million generated in Q3 alone against only $73.5 million of capex. Debt-to-equity has fallen to 0.66 from over 0.72 as roughly $1.75 billion of debt was repaid in Q2, materially reducing balance-sheet risk.
- Cheap on forward and asset multiples: The stock trades at 17.65x forward earnings, 0.77x sales, 1.28x book, 12.40x EV/EBITDA, and a PEG of 0.82 — all undemanding for a branded industrial with ~30% gross margins. Price-to-book sits in the lower half of its historical 1.13x–1.86x band, leaving room for multiple expansion if the recovery holds.
Bearish
- Stock has run past analyst fair value: The average analyst target of $112.00 sits below the current $114.85, implying roughly -2.5% downside to consensus. With 11 Hold ratings against only 4 Buys and a recommendation mean of 2.47, the sell-side is signaling the re-rating has already captured the recovery.
- Revenue is flat, not growing: Q3 2026 revenue of $3.732 billion was down 0.65% year over year, and trailing four-quarter revenue of $15.22 billion shows similar stagnation, oscillating between $3.685 billion and $3.961 billion. The entire thesis rests on margin expansion, which caps the structural growth premium the market can assign.
- Dividend not covered by earnings: The 4.32% yield comes with a payout ratio of 1.25x earnings, meaning the dividend is funded from cash flow rather than GAAP profit. Trailing net margin of 2.66% and ROE of 4.44% remain far below what a scaled industrial should earn, so the recovery is real but incomplete.
- Thin liquidity and interest burden: The current ratio of 1.14 and cash of $749.1 million are adequate but not generous, and Q3 interest expense of $92.3 million against $491.4 million of operating income leaves modest coverage. Any demand deterioration would pressure both the margin recovery and debt service simultaneously.
SWK Technical Analysis
SWK is in a powerful, sustained uptrend: the stock is up 70.22% over the past year and 50.19% year-to-date, and at $114.85 it sits at roughly 90.7% of its 52-week range of $61.90 to $122.68. That positioning near the upper end of the range signals strong momentum but also leaves little margin for error, since the stock is trading just 6.4% below its 52-week high while having more than doubled off the low. The trend structure is clearly bullish, with higher lows throughout 2026 and a decisive break above the mid-$90s consolidation zone in late October.
Short-term momentum is accelerating rather than fading: the stock gained 30.05% in the past month alone versus a 4.99% decline for the S&P 500, a relative-strength spread of 35.04 percentage points, and it is up 10.55% over three months and 41.67% over six months. The most striking feature is the single-session gap on 2026-11-04, when the stock jumped from $104.62 to $118.33 (roughly +13%) on heavy volume, almost certainly an earnings reaction given the Q3 filing date of 2026-11-04; the shares have since consolidated modestly to $114.85. This acceleration is consistent with, not divergent from, the one-year trend, though the vertical nature of the move raises near-term mean-reversion risk, and the elevated short ratio of 4.99 suggests short covering may have amplified the rally.
Key technical levels are well defined: resistance sits at the 52-week high of $122.68, roughly 6.8% above the current price, and a clean breakout above that level would confirm the uptrend and likely invite momentum buyers, while the 52-week low of $61.90 marks the deep support zone some 46% below current levels. More relevant near-term support lies in the $104-$106 area, the pre-gap consolidation zone; a breakdown below that would signal the earnings gap is failing and expose the $95-$99 shelf. With a beta of 1.158, SWK is about 16% more volatile than the market, and its maximum drawdown of -26.95% over the period underscores that position sizing should account for meaningful downside swings despite the current uptrend.
Beta
1.16
1.16x market volatility
Max Drawdown
-26.9%
Largest decline past year
52-Week Range
$62-$123
Price range past year
Annual Return
+71.0%
Cumulative gain past year
| Period | SWK Return | S&P 500 |
|---|---|---|
| 1m | +30.4% | -2.4% |
| 3m | +13.1% | -2.3% |
| 6m | +53.9% | +2.8% |
| 1y | +71.0% | +11.3% |
| ytd | +51.2% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SWK Fundamental Analysis
Revenue is essentially flat rather than growing: the latest quarter (ended 2026-10-03) delivered $3.732 billion, down 0.65% year over year from $3.756 billion, and the trailing four quarters of $15.22 billion show a similar stagnation, with quarterly revenue oscillating between $3.685 billion and $3.961 billion. The Tools & Outdoor segment dominates the mix, while the disclosed Industrial segment contributed just $492.9 million, and the absence of segment-level growth data limits visibility into which lines are driving or dragging results. The investment case therefore rests on margin and cash-flow improvement rather than top-line expansion, which caps the structural growth premium the market can reasonably assign.
Profitability has inflected sharply. Q3 2026 net income reached $272.1 million (EPS $1.84) versus just $51.4 million a year earlier, lifting net margin to 7.29% from 1.37%, while gross margin expanded to 38.95% from 30.65% and operating margin rose to 13.17% from 9.70%. The sequential progression through 2026 is uneven but upward — gross margin of 30.09% in Q1, 32.97% in Q2, and 38.95% in Q3 — pointing to pricing, cost actions, and productivity gains flowing through. Still, the trailing net margin of 2.66% and ROE of 4.44% remain well below what a scaled industrial should earn, so the recovery is real but far from complete.
Balance-sheet and cash-flow metrics are improving. Free cash flow is $1.72 billion on a trailing basis, with $585 million generated in Q3 alone against capital expenditure of just $73.5 million, and debt-to-equity has fallen to 0.66 from over 0.72 a year earlier as the company repaid roughly $1.75 billion of debt in Q2. Liquidity is adequate but not generous, with a current ratio of 1.14 and cash of $749.1 million, and the payout ratio of 1.25 times earnings flags that the 4.32% dividend yield is not yet fully covered by GAAP earnings, though it is comfortably covered by free cash flow. The combination of strong FCF conversion and deleveraging reduces financial risk, but the thin interest coverage implied by modest operating income relative to debt service keeps the balance sheet a live consideration.
Quarterly Revenue
$3.7B
2026-10
Revenue YoY Growth
-0.7%
YoY Comparison
Gross Margin
39.0%
Latest Quarter
Free Cash Flow
$1.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SWK Overvalued?
Because net income is positive, the PE ratio is the primary metric. SWK trades at 28.86x trailing earnings but only 17.65x forward earnings, and the wide gap implies the market expects a substantial earnings rebound — consistent with consensus EPS of $8.87 versus trailing EPS of $0.035, a comparison that reflects depressed trailing GAAP results rather than a genuine 500x earnings multiple. The forward PE of 17.65x is the more meaningful anchor and is modest for an industrial recovery story.
On other measures the stock looks inexpensive: the price-to-sales ratio of 0.77x, price-to-book of 1.28x, EV/EBITDA of 12.40x, and PEG of 0.82 all sit at levels that suggest the market has not fully priced in the margin recovery. The 0.77x sales multiple is low in absolute terms for a branded industrial with roughly 30% gross margins, though it partly reflects the company's thin net margin of 2.66% and 7.62% operating margin. The 4.32% dividend yield is unusually high for the sector and provides a valuation floor, but the 1.25x payout ratio signals the dividend is being funded from cash flow rather than earnings.
Historical context is instructive: SWK's own PE has ranged from negative territory in loss quarters to 54.3x in Q3 2025 and 44.0x in Q1 2026, while price-to-book has ranged from about 1.13x to 1.86x over the past several years. At 1.28x book the stock sits in the lower half of its historical band, and the forward PE of 17.65x is well below the 28.86x trailing figure, suggesting the market is pricing in continued earnings normalization rather than euphoria. The risk is that the re-rating has already captured much of the recovery, leaving less room for multiple expansion from here.
PE
28.9x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 3x~54x
vs. Industry Avg
23.5x
Industry PE ~23.5x*
EV/EBITDA
12.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the durability of a margin recovery that is doing all the work in the earnings story. Gross margin jumped from 30.65% to 38.95% year over year, but revenue fell 0.65% to $3.732 billion, meaning the entire EPS inflection from $0.34 to $1.84 came from cost and pricing actions rather than volume. Trailing net margin of 2.66% and ROE of 4.44% show how little cushion exists if pricing gives back, and the 1.25x payout ratio means the 4.32% dividend depends on the $1.72 billion of free cash flow continuing. Interest expense of $92.3 million in Q3 against $491.4 million of operating income leaves coverage thin enough that a demand downturn would hit margins and debt service at the same time. Market and competitive risks are dominated by valuation compression after a 70.22% one-year and 30.05% one-month surge. The stock trades above the $112 average analyst target with a recommendation mean of 2.47 and 11 Hold ratings, so there is little sell-side fuel left for further re-rating; JP Morgan has held Underweight since May 2026 and Wells Fargo has repeatedly stayed at Equal Weight. With a beta of 1.158, SWK is about 16% more volatile than the market, and the 35.04-point one-month relative-strength spread versus the S&P 500 is the kind of divergence that historically mean-reverts. A short ratio of 4.99 suggests short covering amplified the November gap, which can unwind just as quickly. The worst-case scenario is a Q4 print where gross margin slips back toward the low-30s on promotional pricing and softer tool demand, puncturing the recovery narrative and forcing the 11 Hold-rated analysts to cut targets. In that chain, the stock would first lose the $104–$106 pre-gap consolidation zone, then test the $95–$99 shelf, with the $96 analyst low target as the realistic floor — roughly -16% from $114.85. A fuller de-rating toward the $61.90 52-week low would represent about -46%, consistent with the -26.95% max drawdown already experienced in this cycle.
FAQ
The most severe risk is margin durability: gross margin jumped 830bps to 38.95% while revenue fell 0.65%, so a promotional pricing give-back toward the 30.09% Q1 2026 level would stall the earnings rebound and could drive the stock toward the $96 analyst low target (-16%). Second is valuation and momentum risk — the stock is up 30.05% in a month versus a 4.99% S&P 500 decline (a 35.04-point relative-strength spread), sits at 90.7% of its 52-week range, and trades above the $112 average target with 11 Hold ratings, leaving little sell-side fuel. Third is financial risk: Q3 interest expense of $92.3 million against $491.4 million of operating income is thin coverage, the current ratio is 1.14, and the 1.25x payout ratio means the dividend depends on free cash flow rather than GAAP earnings. Fourth is macro sensitivity — a beta of 1.158 makes SWK about 16% more volatile than the market, and a -26.95% max drawdown has already occurred in this cycle.
The base case carries 55% probability with a $105–$118 range, assuming gross margin settles in the mid-to-high 30s, revenue stays within the recent $3.69–$3.96 billion quarterly band, and forward EPS tracks near the $8.87 consensus, anchoring the stock around the $112 average analyst target. The bull case (20% probability, $130–$140) requires gross margin to hold near 39% through a seasonally weaker Q4, revenue to turn positive, and continued deleveraging to drive analyst upgrades toward the $140 high target. The bear case (25% probability, $90–$96) assumes promotional pricing compresses margin toward the low-30s, the stock loses the $104–$106 pre-gap zone, and it tests the $96 analyst low target. The base case is most likely because the recovery is cash-backed and the forward multiple is undemanding, but the stock has already run past consensus fair value, capping near-term upside.
On forward earnings the stock looks modestly undervalued; on price relative to consensus it looks fully valued. The trailing PE of 28.86x is distorted by depressed GAAP earnings (trailing EPS of $0.035), so the meaningful anchor is the 17.65x forward PE against $8.87 consensus EPS, which is modest for a branded industrial with roughly 30% gross margins. Supporting multiples are cheap in absolute terms — 0.77x sales, 1.28x book (versus a historical 1.13x–1.86x band), 12.40x EV/EBITDA, and a 0.82 PEG. However, the stock at $114.85 sits above the $112 average analyst target, meaning the market is already paying slightly more than the sell-side's fair value after a 70% one-year re-rating. The valuation implies the market expects earnings normalization to continue but not accelerate; further multiple expansion requires proof that 38.95% gross margin is durable.
The risk/reward is balanced rather than compelling at $114.85. On the positive side, the margin recovery is documented across three quarters (gross margin 30.09% in Q1, 32.97% in Q2, 38.95% in Q3 2026), free cash flow of $1.72 billion comfortably funds the 4.32% dividend, and forward PE of 17.65x with a PEG of 0.82 is undemanding for a branded industrial. The problem is price: the stock trades above the $112 average analyst target (about -2.5% implied downside), 11 of 15 ratings are Hold with a 2.47 recommendation mean, and the shares are up 70.22% in a year and 30.05% in a month. The biggest downside risk is a Q4 gross-margin give-back toward the low-30s, which could take the stock toward the $96 analyst low target, roughly -16%. It is a reasonable buy for a patient investor on a pullback toward $96–$100 while margins hold, but chasing at $114.85 offers little near-term margin of safety.
SWK is better suited to a medium-to-long-term holding period of at least 12–24 months than to short-term trading. The thesis depends on a multi-quarter margin and deleveraging trajectory — gross margin progressing from 30.09% in Q1 to 38.95% in Q3 2026, debt-to-equity down to 0.66, and free cash flow of $1.72 billion — which plays out over several earnings cycles rather than weeks. The 4.32% dividend yield rewards patience, though the 1.25x payout ratio means income depends on cash flow rather than GAAP earnings. Short-term traders face elevated risk: beta of 1.158, a -26.95% max drawdown, a 4.99 short ratio, and a 13% single-session gap on 2026-11-04 that invites mean reversion after a 30.05% one-month surge. A staged entry on pullbacks toward $96–$106 would improve the risk/reward for long-term holders.